Round, Jessica M.
Lee, Cerina
Hanlon, John G.
Hyshka, Elaine
Dyck, Jason R. B.
Eurich, Dean T. http://orcid.org/0000-0003-2197-0463
Funding for this research was provided by:
Canadian Institutes of Health Research (CCSA 163022)
Article History
Received: 17 March 2020
Accepted: 11 June 2020
First Online: 23 June 2020
Ethics approval and consent to participate
: Production of this study has been made possible through a CIHR Catalyst Grant for Cannabis Research in Urgent Priority Areas, funded by the Canadian Centre on Substance Use and Addiction using Health Canada Cannabis Research Initiative funds (CCSA 163022). The views expressed herein do not necessarily represent the views of CCSA or its funders. Informed written signed consent was provided by the patient at the time of first referral which allowed data to be collected and used for clinical and research purposes. All data was released as de-identified data to the researchers. Patients and the public were not involved in the design, conduct and reporting of this research project as it was not applicable to this project. This study is based in part on data provided by Canadian Cannabis Clinics and CanvasRx Inc. The interpretation and conclusions contained herein are those of the researchers and do not necessarily represent the views of Canadian Cannabis Clinics or Canvas Rx Inc., each of whom do not express any opinion in relation to this study.
: Not applicable.
: JRBD is on the board of directors of Aurora Cannabis Inc., which is a for-profit, company licensed for the cultivation and sale of medical cannabis. JGH has worked as a paid advisor and speaker for Canadian Cannabis Clinics. JRBD, and JGH have a financial interest in Aurora Cannabis Inc. DTE and JRBD holds a Mitacs Grant with Aurora as a partner. Mitacs is a national, not-for-profit organization that works with universities, private companies, and both federal and provincial governments, to build partnerships and administer research funding that supports industrial and social innovation in Canada. DTE does not have any past or present financial interest in the companies involved. CL, JMR, and EH, have no conflicts of interest to declare. Moreover, the research funders and companies listed were not involved in any aspect of the design or write-up of the study and all analysis was performed independent from the funders and companies.